Table 3 MVA of OS
From: Galectin-1 is a poor prognostic factor in patients with glioblastoma multiforme after radiotherapy
Parameters | p value | HR (95% CI) |
|---|---|---|
Age (≥ 50 vs. <  50 years) | 0.091 | 1.904 (0.902–4.018) |
Gender (male vs. female) | 0.907 | 1.045 (0.501–2.179) |
ECOG (3–4 vs 0–2) | 0.330 | 1.512 (0.658–3.475) |
Size (≥ 5 cm vs. <  5 cm) | 0.686 | 0.796 (0.263–2.407) |
OP method (non-gross total vs. gross total) | 0.887 | 0.950 (0.465–1.940) |
RT field (whole brain vs. small) | 0.322 | 1.510 (0.667–3.417) |
Galectin-1 (strong vs. weak) | 0.020 | 2.929 (1.180–7.271) |
Galectin-3 (strong vs. weak) | 0.478 | 1.343 (0.594–3.034) |